SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 10.1% Passive Stake in Doximity Inc.
Beneficial Ownership Disclosure
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, revealing a continued beneficial ownership of 10.1% of Doximity Inc.'s Class A Common Stock as of February 28, 2025.
Summary
- FMR LLC and Abigail P. Johnson, as reporting persons, have filed an Amendment No. 2 to Schedule 13G concerning their beneficial ownership in Doximity Inc.
- As of February 28, 2025, the aggregate amount beneficially owned by each reporting person is 13,547,898.16 shares of Doximity Inc.'s Class A Common Stock.
- This ownership represents 10.1% of the Class A Common Stock outstanding.
- FMR LLC holds sole voting power over 13,536,047.51 shares and sole dispositive power over 13,547,898.16 shares.
- Abigail P. Johnson holds sole dispositive power over 13,547,898.16 shares.
- The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Doximity Inc.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership, indicating a neutral sentiment. It does not contain performance data or forward-looking statements that would suggest a positive or negative outlook.
Positives
- The disclosure of a significant 10.1% stake by a major institutional investor like FMR LLC (Fidelity) can be viewed as a vote of confidence in Doximity Inc.'s long-term prospects by a sophisticated investor.
Negatives
- NA
Risks
- NA
Future Outlook
NA
Industry Context
This filing is a routine disclosure of a passive investment stake by a large asset manager in a publicly traded healthcare technology company. It does not provide specific insights into Doximity Inc.'s operational performance or strategic direction, nor does it directly relate to broader industry trends beyond indicating continued institutional interest in the sector.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder's stake, which may offer some reassurance regarding institutional confidence in the company.
- Employees, Customers, Suppliers, Creditors: No direct impact from this beneficial ownership disclosure.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of event which requires the filing of this statement, indicating the beneficial ownership position as of this date. |
| 03/06/2025 | Date the Schedule 13G Amendment No. 2 was signed and filed by FMR LLC and Abigail P. Johnson. |
Keywords
Doximity Inc, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Class A Common Stock, Institutional Investor, Healthcare Technology, Medical Social Network
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.